We are a stem cell company specializing in induced pluripotent stem cell (iPSC)-based platforms for rare neurological diseases.

Founded at ODTÜ Teknokent with the support of the TÜBİTAK BİGG fund (TEYDEB 1812), TiPS Cell set out to make a difference in the field of medical biotechnology.

About Us

Our Mission

At TiPS Cell, we generate high-quality, highly efficient induced pluripotent stem cell (iPSC)-based models for disease modeling, drug screening, and regenerative medicine. Leveraging years of experience, our research team utilizes these advanced platforms to develop innovative diagnostic tools, small-molecule drugs, and cell and gene therapies specifically targeted at rare neurological diseases.

Human iPSC

Human iPSC-derived Oligodendrocytes

Human iPSC-derived Astrocytes

iPSC-derived Neurons

We provide personalized iPSC derivation services for disease modeling, toxicology research, and drug screening studies. Please contact us concerning your research needs involving iPSCs and iPSC-derived neuronal subtypes and glial cells.

We are open to collaboration and we provide consulting on proposals and project management.

We help academic and industrial partners with the training they need, involving pluripotent stem cells, neuronal and glial cultures.